U.S. Mortgage Finance Stock News

Salesforce (CRM) is drawing fresh attention after ZoomInfo updated its MCP integration on Salesforce AgentExchange, linking verified go to market data directly into Slack AI. This move highlights how the Salesforce ecosystem is feeding into its AI story. See our latest analysis for Salesforce. Salesforce's recent product ecosystem headlines arrive as the stock trades at US$209.17, with a 30 day share price return of 27.81% and a 12 month total shareholder return that declined 14.90%. Momentum...

Over the last 7 days, the United States market has dropped by 1.2%, although it has seen a significant rise of 18% over the past year, with earnings forecasted to grow by 17% annually. In this context, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to capitalize on longer-term growth prospects.

Over the last 7 days, the United States market has experienced a slight dip of 1.2%, although it has shown robust growth over the past year with an 18% increase and earnings are projected to grow by 17% annually. In this environment, stocks with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company's operations and future prospects.

Over the last 7 days, the U.S. market has dropped by 1.2%, yet it has shown an impressive rise of 18% over the past year, with earnings forecasted to grow annually by 17%. In this context, identifying stocks that combine affordability with growth potential can be particularly appealing to investors. Although 'penny stocks' might seem like a term from a bygone era, they remain relevant as they often represent smaller or newer companies capable of delivering significant returns when backed by...

Over the last 7 days, the United States market has experienced a slight dip of 1.2%, yet it remains up by an impressive 18% over the past year, with earnings expected to grow by 17% annually. In light of these conditions, identifying reliable dividend stocks can be crucial for investors seeking consistent income and stability amidst fluctuating market trends.

ManpowerGroup recently announced that, effective September 1, 2026, Paychex President and CEO John B. Gibson, Jr. joined its Board of Directors, bringing decades of experience in human capital management, technology-enabled HR solutions, and global service operations. Gibson’s track record in scaling digital HR platforms and integrating major acquisitions, such as Paychex’s purchase of Paycor, introduces valuable expertise that could influence how ManpowerGroup enhances its own technology,...

Recent attention on Shopify (NasdaqGS:SHOP) centers on AppLovin’s deeper integration into its commerce ecosystem, giving merchants more advertising tools fed by Shopify’s rich transaction data. That development arrives alongside continued billings and revenue growth indicators. See our latest analysis for Shopify. At a share price of US$149.25, Shopify’s recent 31.21% 1 month share price return and 42.28% 3 month share price return point to building momentum, even though the year to date...

McDonald's (MCD) has started selling the Red Bull Dragonberry Energizer across U.S. restaurants, marking its first move into energy drinks. The launch targets younger customers and supports broader beverage and loyalty program goals. See our latest analysis for McDonald's. The new energy drink offer arrives while McDonald's shares trade at US$270.95. The stock has posted a 2.3% 30 day share price return but a weaker year to date share price return of 10.7%, and a 1 year total shareholder...

When shipping routes through the Strait of Hormuz and the Red Sea are at risk, attention shifts to oil and gas producers that might be less directly exposed to those chokepoints. This disruption can reshape where capital flows, who secures premium pricing and which stocks investors watch most closely. This article looks at 3 stocks from our Non Middle East Oil & Gas Producers screener that appear positively exposed to the latest news shock. The three stocks highlighted below are just a sample...

AbbVie (ABBV) is back in focus after new lung cancer data at the 2026 World Conference on Lung Cancer, where its investigational therapies in both NSCLC and SCLC reported high objective response rates with manageable safety profiles. See our latest analysis for AbbVie. The latest lung cancer data arrives during a strong run for AbbVie, with a 24.32% 90 day share price return and a 31.62% 1 year total shareholder return suggesting that momentum has been building. If this lung cancer update has...

In August 2026, Surgery Partners, Inc. reported second-quarter 2026 results showing sales of US$848.9 million versus US$826.2 million a year earlier, alongside a higher net loss of US$15.0 million, while also disclosing no share repurchases under its March 2026 buyback authorization to date. Management highlighted that disciplined M&A and portfolio optimization have led to only an immaterial level of acquisitions so far in 2026, and that total M&A spending will fall short of its US$200.0...

F.N.B (FNB) has expanded its Private Family Wealth offering for ultra high net worth clients by adding specialized advisory services and advanced solutions that aim to support long term and multigenerational financial objectives. See our latest analysis for F.N.B. F.N.B's recent move to build out Private Family Wealth comes as the stock shows mixed momentum, with the 7 day share price return declining 4.5%, the 90 day share price return rising 5.1%, and the 1 year total shareholder return at...

Roper Technologies (ROP) drew attention after its Illumia education platform introduced PayPal and Venmo as tuition payment options. This client announcement raises fresh questions about the company’s software driven recurring revenue profile. See our latest analysis for Roper Technologies. The Illumia payment update lands during a period of mixed performance for Roper Technologies, with a 90 day share price return of 28.56% and a year to date share price decline of 5.24%, while the 1 year...

Baxter International has recently appointed John Rogers as Chief Financial Officer and Executive Vice President, adjusted its credit agreement to allow higher net leverage, and expanded its bond tender offer capacity to US$600 million while also naming an interim Chief Accounting Officer and Controller. Together, the leadership refresh in Baxter’s finance organization and the move to repurchase long-dated debt signal a concerted effort to reshape its balance sheet and tighten financial...

Earlier in August 2026, NETSCOUT announced upgrades to its Arbor Edge Defense and Adaptive DDoS Protection platforms to help enterprises and service providers identify and block sophisticated DDoS attacks that evade traditional CDN defenses and originate from compromised IoT devices. By restoring visibility into traffic hidden behind shared CDN infrastructure and extending protection to outbound service-provider traffic, NETSCOUT is targeting a critical blind spot where application...

CME Group (CME) has drawn fresh attention after outlining three new futures initiatives in sports, compute and metals that expand its product set and around the clock trading access for different customer types. See our latest analysis for CME Group. For context, CME Group's 1-month share price return of 7.70% and 7-day share price return of 2.65% suggest momentum has picked up again after a 90-day period when the share price declined 2.68%. The 5-year total shareholder return of 70.23%...

Recent developments at CareDx highlight its growing role in precision medicine and transplant care, underpinned by AI-driven diagnostics such as AlloSure Plus and deeper integration into electronic health record systems. These moves point to CareDx increasingly positioning itself as an infrastructure provider for personalized transplant monitoring, rather than just a single-test diagnostics vendor. We’ll now explore how this push into AI-driven diagnostics and EHR integration may influence...

Tariffs between the US and Canada are no longer just headlines; they are starting to reshape where factories run, where goods are sourced and which companies sit closer to the front of the line when trade costs rise. That shift can create fresh winners and leave others lagging. This article walks through three stocks exposed to this trade story and explains why each could matter for your portfolio decisions today. The three stocks covered below are just a starting sample, and the full screen...

Vornado Realty Trust (VNO) has agreed to a joint venture with Rudin Management and an affiliate of Kenneth C. Griffin to develop a 1.9 million square foot office tower at 350 Park Avenue. See our latest analysis for Vornado Realty Trust. The joint venture announcement comes as Vornado Realty Trust trades at US$37.88, with the share price down 4.63% over the past month but up 15.84% over 90 days and supported by a 71.16% three year total shareholder return. This points to momentum building...

With U.S. public debt above US$40t, long term yields over 5% on the 30 year and no strong policy stimulus in sight, funding costs are becoming a story investors can no longer ignore. Higher discount rates can reshape which stocks benefit from this capital hungry cycle and which struggle. This article walks through three stocks from the private credit and direct lending screener that look particularly exposed to these forces. The three stocks below are just a starting sample, and the full...

In recent weeks, Verizon Communications said it will redeem all of its US$1.25 billion 4.329% Notes due 2028 on September 21, 2026, while also rolling out an exclusive Google Pixel 11 lineup with new Simplicity and Simplicity Pro wireless plans and aggressive device promotions. These moves, combined with a new Google Cloud AI partnership to modernize customer experiences and network intelligence, highlight Verizon’s push toward AI-powered, value-focused connectivity services. We’ll now...

Eli Lilly (LLY) has moved further into obesity and diabetes care with the UK launch of its once daily oral GLP-1 pill Foundayo, orforglipron, shortly after lifting its full year outlook. See our latest analysis for Eli Lilly. The launch of Foundayo comes during a strong run for Eli Lilly’s stock, with a 90 day share price return of 17.91% and a 1 year total shareholder return of 81.69%. This indicates momentum that has built rather than faded over multiple years. If you are interested in how...

Governance concerns come into focus for ASA Gold and Precious Metals On 14 August 2026, investor Alexander Merk filed an exempt solicitation with the SEC that challenges ASA Gold and Precious Metals (NYSE:ASA) board expertise and its approach to shareholder rights. Merk also released a dashboard that tracks key company metrics since the board took over management on 1 July 2026, while highlighting that current overseers reportedly lack precious metals mining experience. See our latest...

Cogent Biosciences, Inc. reported past earnings results for the second quarter and six months ended June 30, 2026, with net losses of US$96.41 million for the quarter and US$193.76 million for the half-year, both higher than the prior year. The widening losses highlight the company’s growing investment in its operations and development efforts, a key consideration for investors assessing its progress. Next, we’ll examine how the widening net losses shape Cogent Biosciences’ investment...